US2009068662A1PendingUtilityA1

Method and test kit for the separation, purification and recycling of long- and short-chain nucleic acids

Assignee: AJ INNUSCREEN GMBHPriority: Dec 7, 2005Filed: Jun 9, 2008Published: Mar 12, 2009
Est. expiryDec 7, 2025(expired)· nominal 20-yr term from priority
Inventors:Timo Hillebrand
C12N 15/1006Y10T436/143333
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Long- and/or short-chain nucleic acids are separated, purified and recovered by binding the nucleic acid to a solid phase using a binding buffer, to obtain a bonded nucleic acid, and eluting of the bonded nucleic acid from the solid phase, wherein the binding buffer comprises at least one citric acid salt and at least one alcohol.

Claims

exact text as granted — not AI-modified
1 . A method for the separation, purification and recovery of a long- and/or short-chain nucleic acid, comprising:
 binding the nucleic acid to a solid phase by using a binding buffer, to obtain a bonded nucleic acid; and   eluting of the bonded nucleic acid from the solid phase;   wherein the binding buffer comprises at least one citric acid salt and at least one alcohol.   
   
   
       2 . The method according to  claim 1 , wherein the binding buffer does not comprise (i) a chaotropic salt, or (ii) a combination of a salt with a monovalent cation and a salt with a multivalent cation. 
   
   
       3 . The method according to  claim 1 , wherein the citric acid salt represents a salt with a singly positively charged cation. 
   
   
       4 . The method according to  claim 1 , wherein a hydrogen citrate or a dihydrogen citrate or a mixture thereof is introduced as citric acid salt. 
   
   
       5 . The method according to  claim 1 , wherein the citric acid salt is selected from the group consisting of di-ammonium hydrogen citrate, ammonium dihydrogen citrate, tri-sodium citrate, di-sodium hydrogen citrate, sodium hydrogen citrate, tri-potassium citrate, di-potassium hydrogen citrate, potassium hydrogen citrate and mixtures thereof. 
   
   
       6 . The method according to  claim 1 , wherein an alcohol concentration of the binding buffer is between 20%-90 wt. %. 
   
   
       7 . The method according to  claim 1 , wherein an alcohol concentration of the binding buffer is between 40%-70 wt. %. 
   
   
       8 . The method according to  claim 1 , wherein said alcohol is methanol, ethanol, propanol, isopropanol, ethylene glycol, polyethylene glycol, gycerin or mixtures thereof 
   
   
       9 . The method according to  claim 1 , wherein the ion strength of said binding buffer during said binding of said the nucleic acid to said solid phase is less than 100 mM. 
   
   
       10 . The method according to  claim 1 , wherein the ion strength of said binding buffer during said binding of said the nucleic acid to said solid phase is less than 50 mM. 
   
   
       11 . The method according to  claim 1 , wherein said solid phase is selected form the group consisting of a glass fibre material, a silica gel, a suspension of a mineral support, a functionalized magnetic particle and combinations thereof. 
   
   
       12 . The method according to  claim 1 , wherein said solid phase is a glass fibre material having a length of 0.7 μm to 2 μm. 
   
   
       13 . A method for the separation, purification and recovery of a long- and/or short-chain nucleic acid, comprising:
 adding a binding buffer to a reaction assay containing a nucleic acid, to obtain a mixture;   transferring said mixture to a solid phase, to bind said nucleic acid to said solid phase; and   eluting said nucleic acid from said solid phase;   wherein the binding buffer comprises at least one citric acid salt and at least one alcohol.   
   
   
       14 . The method according to  claim 13 , which does not comprise washing of the nucleic acids bound to the solid phase. 
   
   
       15 . The method according to  claim 13 , wherein the binding buffer does not comprise (i) a chaotropic salt, or (ii) a combination of a salt with a monovalent cation and a salt with a multivalent cation. 
   
   
       16 . The method according to  claim 13 , wherein the citric acid salt represents a salt with a singly positively charged cation. 
   
   
       17 . The method according to  claim 13 , wherein a hydrogen citrate or a dihydrogen citrate or a mixture thereof is introduced as citric acid salt. 
   
   
       18 . The method according to  claim 13 , wherein the citric acid salt is selected from the group consisting of di-ammonium hydrogen citrate, ammonium dihydrogen citrate, tri-sodium citrate, di-sodium hydrogen citrate, sodium hydrogen citrate, tri-potassium citrate, di-potassium hydrogen citrate, potassium hydrogen citrate and mixtures thereof. 
   
   
       19 . The method according to  claim 13 , wherein an alcohol concentration of the binding buffer is between 20%-90 wt. %. 
   
   
       20 . The method according to  claim 13 , wherein said alcohol is methanol, ethanol, propanol, isopropanol, ethylene glycol, polyethylene glycol, gycerin or mixtures thereof 
   
   
       21 . The method according to  claim 13 , wherein the ion strength of said binding buffer during said binding of said the nucleic acid to said solid phase is less than 100 mM. 
   
   
       22 . The method according to  claim 13 , wherein said solid phase is selected form the group consisting of a glass fibre material, a silica gel, a suspension of a mineral support, a functionalized magnetic particle and combinations thereof. 
   
   
       23 . The method according to  claim 13 , wherein said solid phase is a glass fibre material having a length of 0.7 μm to 2 μm. 
   
   
       24 . A test kit for carrying out the method according to  claims 1  or  13 , comprising:
 at least one alcohol;   at least one citric acid salt;   a solid phase; and   an elution buffer.   
   
   
       25 . A method for the purification of a PCR product, a restriction assay or a sequencing assay, comprising:
 contacting the test kit of  claim 24  with a PCR product, a restriction assay or a sequencing assay.

Join the waitlist — get patent alerts

Track US2009068662A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.